For the quarter ending 2026-03-31, HUBS had $61,695K increase in cash & cash equivalents over the period. $183,403K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 32,554 | 54,426 | 16,536 | -25,051 |
| Depreciation and amortization | 40,239 | 38,569 | 35,702 | 62,024 |
| Stock-based compensation | 115,744 | 132,399 | 138,086 | 257,668 |
| Gain on strategic investments | 747 | 3,514 | 117 | 1,869 |
| Impairment of strategic investments | 913 | 2,248 | 2,075 | 1,600 |
| Benefit from deferred income taxes | -73 | 268 | -56 | -214 |
| Amortization of debt discount and issuance costs | 97 | 0 | 0 | 577 |
| Accretion of bond discount | 6,789 | 7,046 | 8,979 | 24,443 |
| Unrealized currency translation | -2,527 | 3,857 | -942 | 2,777 |
| Accounts receivable | -58,437 | 99,813 | -5,780 | -30,030 |
| Prepaid expenses and other assets | 60,519 | -3,149 | -12,871 | 50,080 |
| Deferred commission expense | -22,092 | -43,879 | -23,563 | -49,590 |
| Right-of-use assets | 7,402 | 6,573 | 6,493 | 12,828 |
| Accounts payable | 31,319 | -1,132 | 11,010 | 9,121 |
| Accrued expenses and other liabilities | -24,709 | 56,354 | 1,741 | 59,876 |
| Operating lease liabilities | 13,859 | 9,823 | 8,645 | 17,656 |
| Deferred revenue | 38,381 | 122,508 | -2,521 | 63,888 |
| Net cash and cash equivalents provided by operating activities | 198,825 | 247,430 | 187,355 | 325,932 |
| Purchases of investments | 358,691 | 258,999 | 354,795 | 830,204 |
| Maturities of investments | 487,690 | 351,450 | 580,428 | 1,305,509 |
| Proceeds from strategic investments | - | 2,738 | - | - |
| Purchases of property and equipment | 15,422 | 13,450 | 10,345 | 29,370 |
| Purchases of strategic investments | 5,792 | 4,936 | 8,922 | 18,825 |
| Purchases of intangible assets | 527 | -5 | 23 | 256 |
| Capitalization of software development costs | 34,339 | 30,269 | 34,498 | 65,857 |
| Business acquisitions, net of cash acquired | 8,341 | 16,137 | 1,638 | 69,833 |
| Net cash and cash equivalents provided by investing activities | 64,578 | 30,402 | 170,207 | 291,164 |
| Repayment of 2025 convertible notes | - | 459,811 | - | - |
| Employee taxes paid related to the net share settlement of stock-based awards | 3,194 | 3,397 | 4,364 | 13,812 |
| Payment for settlement of 2025 convertible notes | - | - | 0 | 459,811 |
| Payment of debt issuance costs | 2,620 | - | - | - |
| Proceeds related to the issuance of common stock under stock plans | 16,313 | 8,677 | 24,053 | 38,664 |
| Repurchases of common stock | 206,681 | 14,746 | 360,269 | 125,004 |
| Net cash and cash equivalents used in financing activities | -196,182 | -9,466 | -340,580 | -559,963 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -5,526 | -476 | -3,826 | 30,046 |
| Net increase in cash, cash equivalents and restricted cash | 61,695 | 267,890 | 13,156 | 87,179 |
| Cash, cash equivalents and restricted cash, beginning of period | 884,945 | 617,055 | 516,720 | - |
| Cash, cash equivalents and restricted cash, end of period | 946,640 | 884,945 | 617,055 | - |